The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1056674510 10566745 10 F 2012 20160701 20141105 20160706 EXP PHHY2013BR006425 NOVARTIS 57.89 YR F Y 42.00000 KG 20160706 MD BR BR

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1056674510 10566745 1 SS XOLAIR OMALIZUMAB 1 Subcutaneous 150 MG, 1 AMPOULE, QMO 0 150 MG /month
1056674510 10566745 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous 150 MG, EACH 15 DAYS 0 150 MG
1056674510 10566745 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous 150 MG, QMO (TWICE) 0 150 MG /month
1056674510 10566745 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous 150 MG, QMO 0 150 MG /month
1056674510 10566745 5 PS ONBREZ BREEZHALER INDACATEROL 1 Unknown U 22383 DRY POWDER INHALER
1056674510 10566745 6 SS HIGROTON CHLORTHALIDONE 1 Unknown U 0
1056674510 10566745 7 SS PREDNISONE. PREDNISONE 1 Unknown 0
1056674510 10566745 8 SS FORASEQ BUDESONIDEFORMOTEROL FUMARATE 1 Unknown U 0
1056674510 10566745 9 SS SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0
1056674510 10566745 10 SS LANTUS INSULIN GLARGINE 1 Unknown U 0
1056674510 10566745 11 SS OXYGEN. OXYGEN 1 Unknown 0
1056674510 10566745 12 C GABAPENTIN. GABAPENTIN 1 Oral 1 DF (400 MG), QD 0 1 DF TABLET QD
1056674510 10566745 13 C DAXAS ROFLUMILAST 1 Unknown UNK, QOD 0 TABLET
1056674510 10566745 14 C DAXAS ROFLUMILAST 1 Oral 500 MG, QD (STARTED 2 YEARS AGO) 0 500 MG TABLET QD
1056674510 10566745 15 C BAMIFIX BAMIFYLLINE HYDROCHLORIDE 1 Unknown 1 DF, QD 0 1 DF TABLET QD
1056674510 10566745 16 C BAMIFIX BAMIFYLLINE HYDROCHLORIDE 1 Oral 2 DF, 2 TAB/DAY (300 MG), QD (2 YEARS AGO) 0 2 DF TABLET QD
1056674510 10566745 17 C ALENIA /01538101/ BUDESONIDEFORMOTEROL FUMARATE 1 Unknown 2 DF, QD 0 2 DF TABLET QD
1056674510 10566745 18 C ALENIA /01538101/ BUDESONIDEFORMOTEROL FUMARATE 1 Respiratory (inhalation) 12 + 400 (UNITS UNSPECIFIED), BID (STARTED 2 YEARS AGO) 0 TABLET BID
1056674510 10566745 19 C PREDSIM PREDNISOLONE 1 Unknown 0
1056674510 10566745 20 C CLAVULIN AMOXICILLINCLAVULANIC ACID 1 Unknown 0
1056674510 10566745 21 C VENLAFAXINE VENLAFAXINE HYDROCHLORIDE 1 Unknown 1 DF, QD 0 1 DF TABLET QD
1056674510 10566745 22 C D-3 CHOLECALCIFEROL 1 Unknown 1 DF, QD 0 1 DF TABLET QD
1056674510 10566745 23 C PURAN LEVOTHYROXINE SODIUM 1 Unknown 1 DF, QD 0 1 DF TABLET QD
1056674510 10566745 24 C CLONAZEPAM. CLONAZEPAM 1 Unknown 1 DF, QD 0 1 DF TABLET QD
1056674510 10566745 25 C DUOVENT FENOTEROL HYDROBROMIDE 1 Unknown UNK (2 YEARS AGO) 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1056674510 10566745 1 Asthma
1056674510 10566745 2 Bronchiectasis
1056674510 10566745 5 Product used for unknown indication
1056674510 10566745 6 Product used for unknown indication
1056674510 10566745 7 Product used for unknown indication
1056674510 10566745 8 Product used for unknown indication
1056674510 10566745 9 Product used for unknown indication
1056674510 10566745 10 Product used for unknown indication
1056674510 10566745 11 Product used for unknown indication
1056674510 10566745 12 Product used for unknown indication
1056674510 10566745 13 Cough
1056674510 10566745 14 Dyspnoea
1056674510 10566745 15 Lung disorder
1056674510 10566745 16 Bronchial disorder
1056674510 10566745 17 Lung disorder
1056674510 10566745 18 Asthma
1056674510 10566745 19 Product used for unknown indication
1056674510 10566745 20 Product used for unknown indication
1056674510 10566745 21 Depression
1056674510 10566745 22 Thyroid disorder
1056674510 10566745 23 Thyroid disorder
1056674510 10566745 24 Sleep disorder
1056674510 10566745 25 Dyspnoea

Outcome of event

Event ID CASEID OUTC COD
1056674510 10566745 LT
1056674510 10566745 HO
1056674510 10566745 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1056674510 10566745 Asthenia
1056674510 10566745 Asthmatic crisis
1056674510 10566745 Bladder disorder
1056674510 10566745 Blood disorder
1056674510 10566745 Coma
1056674510 10566745 Cough
1056674510 10566745 Dyspnoea
1056674510 10566745 Lung disorder
1056674510 10566745 Oxygen consumption decreased
1056674510 10566745 Pneumonia
1056674510 10566745 Product use issue
1056674510 10566745 Speech disorder
1056674510 10566745 Thrombosis
1056674510 10566745 Weight decreased
1056674510 10566745 Weight increased
1056674510 10566745 Wound

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1056674510 10566745 1 2012 2012 0
1056674510 10566745 2 20121207 0
1056674510 10566745 3 2013 0